Image

EPIC: An Intervention for Early-stage AD Dyads - Adapted for Virtual Delivery

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

EPIC II (Early-Stage Partners in Care) is a research project designed to assist people with early-stage memory loss and their care partners by providing early-stage related education and skill-training sessions, held via Zoom, designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.

Description

The purpose of this study is to help early-stage individuals who have early-stage memory loss or early stage dementia and their current or future care partners by providing education and skill-training programs, held via Zoom, designed to reduce stress and distress, increase well-being and quality of life, and plan for the future. About 160 early-stage dyads (person with early-stage dementia and his/her care partner) will be enrolled across the United States through Arizona State University.

People who decide to voluntarily participate in this program, will be asked to:

  • Meet others with memory loss and their care partners.
  • Attend six group sessions via Zoom (2 hours & 30 minutes each) to learn strategies to help handle new situations, reduce stress, improve mood, communicate better with each other, and plan for the future.
  • Participate in one 90-minute individualized session via Zoom to address specific issues that may be unique to each dyad's situation.
  • Participate in three 2-hour confidential interviews that involve questions about background, mood, and quality of life.
  • Participate in interviews at the start, and again about 3 and 6 months, via Zoom, to help us to continue to improve the program.
  • Attend several monthly booster sessions after completion of the seven EPIC sessions.

Each person will receive up to $45 for completing all follow-up interviews, or $20- 25 for each interview completed. All participants are offered the EPIC sessions shortly after their first interview or shortly after their 3-month interview. Some participants will also attend an additional free education workshop within one month of the initial assessment.

Eligibility

DYAD INCLUSION CRITERIA:

  1. All participants - Care Partners (CP) and Early-Stage People (EP) - will be at least 18 years of age and speak, read, and write English or Spanish.
  2. Eligible dyad relationships include spouse, adult-child relationships (e.g., daughters), and other close friends and family members.
  3. Care partners must self-identify as the person who currently has or who expects to have the most hands-on responsibility and ongoing involvement with the EP.
  4. CPs must live with or have regular contact with the EP.
  5. EPs and CPs must reside in a community setting.

EP INCLUSION CRITERIA:

  1. Live at home rather than an institutional setting,
  2. Have a confirmed diagnosis of OR symptoms consistent with early-stage dementia
  3. Exhibit changes in memory as specified on the AD8 dementia screening tool.
  4. Have a Mini-Mental State Exam (MMSE)i score within a protocol-specified range.
  5. Have a CP who is defined by the EP as being the unpaid "family member" who has or will have primary responsibility for providing assistance to the EP

EP EXCLUSION CRITERIA:

  1. Denying or not reporting any trouble with memory, based on self-report
  2. Normal cognition, based on score derived from screening tool
  3. If yes to BOTH:
    1. severe mental illness or developmental disability before the age of 45
    2. memory problems due to past head injury

Study details

Dementia, Alzheimer Disease, Memory Loss

NCT03144921

Arizona State University

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.